Debio 0507 | Pipeline | / | Products

Menu Content/Inhalt

Home|Careers|Contact us

News

02.09.2008
Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate For Cancer Treatment
21.08.2008
Doctor Manel Esteller Receives the Debiopharm Life Sciences Award For his Outstanding Research in Epigenetic Oncology

Debio 0507

Debio 0507 is a new generation DACHplatin cytotoxic nanoparticular compound in preclinical development.

Press Releases

31-Oct-2007

Debiopharm and Nanocarrier sign License and Supply Agreement for DACH-Platin Polymeric Micelle in Oncology

30-Mar-2006

Debiopharm S.A. invests in NanoCarrier Mezzanine Funding Round

21-Apr-2005

Debiopharm and NanoCarrier form Research Collaboration on a new platinum compound using the Medicelle TM technology